Lucanthone
Source: Wikipedia, the free encyclopedia.
Chemical compound
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
ECHA InfoCard | 100.006.849 |
Chemical and physical data | |
Formula | C20H24N2OS |
Molar mass | 340.49 g·mol−1 |
NY (what is this?) (verify) |
Lucanthone is a drug used to treat parasitic diseases such as
bilharziasis[1] and schistosomiasis[2] It is a prodrug and is converted to the active metabolite hycanthone.[3]
Mechanism of action
Hycanthone binds to
5-HT causing increase in motility, paired worms are separated and reproduction is stopped. It causes damage of the integument and vitelline duct
.
References
- PMID 13573122.
- ISBN 978-1-4832-7308-2.
- PMID 4963368.
- PMID 1190369.
|
| |||||||
---|---|---|---|---|---|---|---|---|
Anticestodals (taeniacides) |
|
macrofilaricides)
Binds tubulin | |
---|---|
Glutamate-gated chloride channel, GABA receptor | |
NMDA | |
Other/unknown |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
drug article is a stub. You can help Wikipedia by expanding it. |